Hints and tips:
Related Special Reports
...David Moore, vice-president for corporate development, added that the company would focus on acquisitions in diabetes and obesity, ideally in the early stage of development....
...“People are fixated on the size of these companies,” said Vontobel portfolio manager David Souccar. “[If] a small-cap compounds by 50 per cent over five years . . ....
...David Roche, a Colorado-based running coach, says that easy running is key to improvement, and should encompass at least 80 per cent of training for most athletes....
...His total pay package at Roche, which he has led since 2008, was SFr11mn in 2020....
...This month the company appointed Chris Smith, chief executive of Nasdaq-listed Ortho Clinical Diagnostics to chair the board, and David Berry, general partner at healthcare venture capital firm Flagship...
...Illumina was the fourth-largest spender on lobbying among biotech and pharma companies in 2022 at $9.4mn, behind only Pfizer, Roche and Amgen, which are much larger companies, according to an analysis by...
...The drug builds on a history of targeting the HER2 protein which dates back to Roche’s launch of Herceptin in 1998....
...David Ferrall, head of trading platform FinClear, laid the blame on ASX and regulators who “blindly” accepted that the upgrade would deliver on its original promise....
...With that in mind, thank you David Hindley for guiding this newsletter ship in my absence these past two weeks....
...Job moves Former Roche boss Bill Anderson will become the next chief executive of Bayer. His predecessor Werner Baumann has faced pressure from activist investors including Jeff Ubben....
...Other competitors such as Exact Sciences, based in Wisconsin, and San Francisco’s Freenome, a start-up backed by Roche, are racing to launch their own tests....
...The company was created by researcher Jonathan Milner, his professor Tony Kouzarides and David Cleevely, an entrepreneur and advocate for investment in Cambridge....
...David Fredrickson, AstraZeneca’s executive vice-president of oncology, said Enhertu had the potential to become a “multi-blockbuster” medicine by being transformative in treating different types of breast...
...For example, “Roche’s Favourite” started its life as a Scottish strathspey in Victorian times....
...The hand subject is sourced from a photo by Mexican mural painter David Alfaro Siqueiros (1896-1974), himself caught between dreams of revolution and a life of luxury....
...Mr Davis said his company would be able to expand quickly were it not for a shortage of chemical reagents and machines from testing equipment makers such as Roche, ThermoFisher and Hologic, which are struggling...
...Dassault Systemes Q4, Eli Lilly and Co Q4, Enel FY, ICE Q4, Infineon Technologies Q3, ING Q4, Merck & Co Q4, Nintendo Q3, Nokia FY, Norton LifeLock Q3, OMV Q4, Prudential Financial Q4, Ralph Lauren Q3, Roche...
...Job moves Evercore has hired David Lischer as a senior managing director in its debt advisory practice. He joins from Goldman Sachs....
...But Merrill chief executive David Komansky had a coarse tongue, and no intention of letting that happen. “What the fuck are you doing?” he yelled at Fink. “Just do the IPO....
...SoftBank has quietly built a $5bn stake in Roche, believing the Swiss pharmaceutical group’s Genentech data-based drug discovery division is highly undervalued, Bloomberg reported....
...Michelin’s plan is the extension of a review of its European business launched in mid-2019 that saw the group shut a factory in La Roche-sur-Yon in the west of France and another in Germany....
...In contrast, L’Oréal’s skincare division, which sells brands like Kiehls and La Roche-Posay, has surged despite the forced closure of stores and beauty salons in much of Europe....
...In doing so, he has ventured on to the terrain of the far-right, “opening the door to their narratives”, Mr Roché said. “It is a strategy . . . but that strategy is risky,” he added....
...“It’s an eagerly awaited return for us and our customers,” said David Howson, president of Cboe Europe, which lost 9 per cent of its business, by value traded, when the ban was imposed....
...David Cameron faces Greensill questions The former UK prime minister will face scrutiny over his lobbying for Greensill Capital, which collapsed in March....
International Edition